Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study

CONCLUSIONS: The efficacy of once-weekly somatrogon was non-inferior to once-daily somatropin, with similar safety and tolerability profiles.PMID:35405011 | DOI:10.1210/clinem/dgac220

Source: The Journal of Clinical Endocrinology and Metabolism - April 11, 2022 Category: Endocrinology Authors: Cheri Deal Joel Steelman Elpis Vlachopapadopoulou Renata Stawerska Lawrence A Silverman Moshe Phillip Ho-Seong Kim Cheol Woo Ko Oleg Malievskiy Jose F Cara Carl L Roland Carrie Turich Taylor Srinivas Rao Valluri Michael P Wajnrajch Aleksandra Pastrak Brad Source Type: research